CTRI/2022/03/041250尚未招募4 期
The immunomodulatory effect of homoeopathic drug arsenicum album in children with wheeze
DrSanthosh Kumar0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Children between the age of 2 to 5 years suffering from repeated attacks of cold and cough with wheeze of unspecified ethology for more than 3 times in a year with the gap of less than 2 months will be selected for the study.
排除标准
- •1.Children should not be under Homoeopathic treatment for the given condition for at least three months. (wash out period)
- •2.Presence of obstructive lung disease
- •3.Other Cardiovascular disease
- •4.Known chronic infections
- •5.Congenital disorders
- •6.Known malignancy
- •7.Inflammatory connective tissue
- •8.Should not have received steroid for any clinical conditions for the last three months.
研究者
相似试验
招募中
3 期
Immunomodulatory effect of an herbal supplement containing Fenugreek, Nigella sativa ?and Sumac in patients with type 2 diabetesIRCT20141209020258N144Arak University of Medical Sciences72
已完成
不适用
Investigational study on immunomodulatory effect of lenvatinib in clinical specimens - Future oriented approach for lenvatinib on tumor microenvironment and cancer regression (FLORENCE)Hepatocellular carcinomaJPRN-UMIN000044924Hiroshima University50
已完成
2 期
To study the effect of Amalakyadi Rasayan in reducing the frequency of illness in children by improving the immunity and increasing the body strengthCTRI/2019/06/019686ational Institute of Ayurveda Jaipur60
已完成
2 期
The effect of a mixed Chinese herbal formula on the immune system of people who have perennial allergic rhinitis, a condition where the immune system overreacts to year-round allergens and causes symptoms like sneezing and congestion in the noseTreatment with a mixed Chinese herbal formula for patients with allergic rhinitisEar, Nose and ThroatISRCTN22925852Taoyuan Chang Gung Memorial Hospital49
已完成
不适用
Immunomodulatory effects of a proprietary Arabinogalactan extractImmune response to the 23-valent pneumococcal vaccineRespiratoryPneumonia vaccinationISRCTN98817459onza, Inc (USA)50